NSE ScannerOpen the scanner

Comparison · NSE · data 2026-10-30

Torrent Pharmaceuticals Ltd vs Zydus Lifesciences Limited

In plain words

Size: Torrent Pharmaceuticals Ltd is about 1.5 times the market value of Zydus Lifesciences Limited.

Valuation (P/E): Torrent Pharmaceuticals Ltd 75.6 vs Zydus Lifesciences Limited 27.8.

Return on equity: Torrent Pharmaceuticals Ltd 27.1% vs Zydus Lifesciences Limited 19.7%.

Profit growth over 3 years: Zydus Lifesciences Limited 37% a year vs Torrent Pharmaceuticals Ltd 20.2% a year.

Debt to equity: Torrent Pharmaceuticals Ltd 1.79 vs Zydus Lifesciences Limited 0.46.

Differences in the numbers, not a recommendation of either stock.

Side by side

TORNTPHARMZYDUSLIFE
Price₹4,613.4₹1,245.5
Market cap₹1,73,597 cr₹1,18,304 cr
P/E75.627.8
P/B9.6—
ROE27.1%19.7%
ROCE13.5%17.8%
Debt / equity1.790.46
Operating margin22.1%18.6%
Dividend yield0.83%0.08%
Sales growth, 3 years (yearly)12.5%16.6%
Profit growth, 3 years (yearly)20.2%37.0%
1-year return28.0%24.1%
Revenue, last 12 months₹17,400 cr₹28,592 cr
Net profit, last 12 months₹2,124 cr₹4,513 cr
Latest quarterDec 2025Mar 2024
Quarter net profit₹635 cr₹64 cr
Quarter profit vs a year earlier——
Promoter holding68.31%75.01%
Health checkAverage (4.9/10)Strong (7.9/10)

Common questions

Which has a higher P/E, Torrent Pharmaceuticals Ltd or Zydus Lifesciences Limited?

Torrent Pharmaceuticals Ltd trades at the higher P/E (75.6 against 27.8). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.

Which earns a higher return on equity?

Torrent Pharmaceuticals Ltd (27.1% against 19.7%).

Which carries more debt?

Torrent Pharmaceuticals Ltd has the higher debt-to-equity ratio (1.79 against 0.46).

TORNTPHARM pageZYDUSLIFE page

Share on WhatsAppShare on Telegram